Alexandra C. Villasante Fricke

TL;DR: AA is the most prevalent autoimmune disorder and the second most prevalent hair loss disorder after androgenetic alopecia, and the lifetime risk in the global population is approximately 2%.

TL;DR: It is concluded that EAT measurement serves as a powerful potential diagnostic tool in assessing cardiovascular and metabolic risk and modification of EAT thickness has therapeutic implications for ASCVD, T2DM, and MetS.

TL;DR: Weekly administration of either GLP-1 receptor agonists semaglutide or dulag lutide causes a rapid, substantial, and dose-dependent reduction in EAT thickness.

TL;DR: It is shown that skin wounding protects from alopecia caused by several clinically relevant chemotherapeutic regimens, and that protection is dependent on the time of wounding and hair cycle stage, and it is concluded that wound healing switches the cutaneous cytokine milieu to an IL-1β-dominated state thus retarding HF growth progression and rendering the HFs resistant to chemotherapy agents.

TL;DR: In this article , the characteristics of the resulting X-ray emission by means of the radiation dose, is investigated for various irradiation and process parameters, including material (steel and bismuth), intensity (max. 3*1014 W/cm²), polarization, surface roughness (0.1 µm < Ra < 13 µm) and pulse duration (095 ps − 10 ps).